Create a Free Account
or
HIMS Hims & Hers Health, Inc.
NYSE forhims.com
$ 41.21 $ 0.33 (0.8 %)
Friday, 07-Nov-2025 19:57:59 EST
Create a Free Account
or
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Hims & Hers Health (HIMS) CEO Andrew Dudum, sees potential for emotional and medical transformation and plans for global ex...
B of A Securities analyst Allen Lutz maintains Hims & Hers Health (NYSE:HIMS) with a Underperform and raises the price t...
BTIG analyst David Larsen reiterates Hims & Hers Health (NYSE:HIMS) with a Buy and maintains $85 price target.
PLTR, KMB, HIMS, NVTS, CIFR were among the stocks seen trending among investors on Monday, Nov. 3, 2025.
Hims & Hers Health (NYSE:HIMS) reported quarterly earnings of $0.09 per share which missed the analyst consensus estimate o...
Here's a look at the Q3 earnings report from Hims & Hers Health.
Discussions with Novo NordiskHims & Hers and Novo Nordisk are in active discussions to make Wegovy injections and Novo Nord...
Hims & Hers Health (NYSE:HIMS) narrows FY2025 sales outlook from $2.300 billion-$2.400 billion to $2.335 billion-$2.355 bil...
Hims & Hers Health (NYSE:HIMS) sees Q4 sales of $605.000 million-$625.000 million vs $631.685 million analyst estimate.
